Induced Pluripotent Stem Cells Show Metabolomic Differences to Embryonic Stem Cells in Polyunsaturated Phosphatidylcholines and Primary Metabolism

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Meissen, John K ^a   Yuen, Benjamin T K ^b   Kind, Tobias ^a   Riggs, John W ^b   Barupal, Dinesh K ^a   Knoepfler, Paul S ^a,b   Fiehn, Oliver ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; ESSENTIAL AMINO ACID; FATTY ACID; HYDROXYL ACID; HYDROXYL GROUP; NONESSENTIAL AMINO ACID; PENTOSE PHOSPHATE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; UNCLASSIFIED DRUG; AMINO ACID;

ARTICLE; CARBOHYDRATE METABOLISM; CELL METABOLISM; CHEMICAL STRUCTURE; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; FIBROBLAST; GAS CHROMATOGRAPHY TIME OF FLIGHT MASS SPECTROMETRY; HYDROPHILIC INTERACTION CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITE; METABOLOMICS; MOUSE; NANOELECTROSPRAY ION TRAP MASS SPECTROMETRY; NONHUMAN; PLURIPOTENT STEM CELL; POLYAMINE SYNTHESIS; REVERSED PHASE LIQUID CHROMATOGRAPHY QUADRUPOLE TIME OF FLIGHT MASS SPECTROMETRY; ANIMAL; DOWN REGULATION; MASS FRAGMENTOGRAPHY; METABOLISM;

AMINO ACIDS; ANIMALS; DOWN-REGULATION; EMBRYONIC STEM CELLS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; METABOLOMICS; MICE; PHOSPHATIDYLCHOLINES; PLURIPOTENT STEM CELLS;

EID: 84867487610     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046770     Document Type: Article

References (48)

1. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
2. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell 131: 861-872.
3. Lowry WE, Richter L, Yachechko R, Pyle AD, Tchieu J, et al. (2008) Generation of human induced pluripotent stem cells from dermal fibroblasts. Proceedings of the National Academy of Sciences of the United States of America 105: 2883-2888.
4. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, et al. (2007) Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1: 55-70.
5. Mikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, et al. (2008) Dissecting direct reprogramming through integrative genomic analysis. Nature 454: 49-55.
6. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
7. Cantz T, Martin U, (2010) Induced pluripotent stem cells: characteristics and perspectives. Advances in Biochemical Engineering/Biotechnology 123: 107-126.
8. Amabile G, Meissner A, (2009) Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends in Molecular Medicine 15: 59-68.
9. Hanna JH, Saha K, Jaenisch R, (2010) Pluripotency and Cellular Reprogramming: Facts, Hypotheses, Unresolved Issues. Cell 143: 508-525.
10. Boland MJ, Hazen JL, Nazor KL, Rodriguez AR, Gifford W, et al. (2009) Adult mice generated from induced pluripotent stem cells. Nature 461: 91-94.
11. Kang L, Wang J, Zhang Y, Kou Z, Gao S, (2009) iPS cells can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell 5: 135-138.
12. Zhao X-y, Li W, Lv Z, Liu L, Tong M, et al. (2009) iPS cells produce viable mice through tetraploid complementation. Nature 461: 86-90.
13. Chin MH, Mason MJ, Xie W, Volinia S, Singer M, et al. (2009) Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5: 111-123.
14. Kim K, Doi A, Wen B, Ng K, Zhao R, et al. (2010) Epigenetic memory in induced pluripotent stem cells. Nature 467: 285-290.
15. Zhao T, Zhang Z-N, Rong Z, Xu Y, (2011) Immunogenicity of induced pluripotent stem cells. Nature 474: 212-215.
16. Gore A, Li Z, Fung H-L, Young J, Agarwal S, et al. (2011) Somatic coding mutations in human induced pluripotent stem cells. Nature 471: 63-67.
17. Hussein SM, Batada NN, Vuoristo S, Ching RW, Autio R, et al. (2011) Copy number variation and selection during reprogramming to pluripotency. Nature 471: 58-62.
18. Laurent LC, Ulitsky I, Slavin I, Tran H, Schork A, et al. (2011) Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8: 106-118.
19. Quinlan AR, Boland MJ, Leibowitz ML, Shumilina S, Pehrson SM, et al. (2011) Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming. Cell Stem Cell 9: 366-373.
20. Fiehn O, (2002) Metabolomics-the link between genotypes and phenotypes. Plant Molecular Biology 48: 155-171.
21. Dettmer K, Aronov PA, Hammock BD, (2007) Mass spectrometry-based metabolomics. Mass Spectrometry Reviews 26: 51-78.
22. Lei Z, Huhman DV, Sumner LW, (2011) Mass Spectrometry Strategies in Metabolomics. Journal of Biological Chemistry 286: 25435-25442.
23. Yanes O, Clark J, Wong DM, Patti GJ, Sánchez-Ruiz A, et al. (2010) Metabolic oxidation regulates embryonic stem cell differentiation. Nature chemical biology 6: 411-417.
24. Jürchott K, Guo K-T, Catchpole G, Feher K, Willmitzer L, et al. (2011) Comparison of metabolite profiles in U87 glioma cells and mesenchymal stem cells. Biosystems 105: 130-139.
25. Panopoulos AD, Yanes O, Ruiz S, Kida YS, Diep D, et al. (2011) The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming. Cell Research doi:10.1038/cr.2011.1177.
26. Riggs JW, Barrilleaux BL, Chan V, Knoepfler PS, (2012) Induced pluripotency and oncogenic transformation are distinct, but highly related processes. Stem Cells and Development (in press).
27. Han X, Yang K, Gross RW, (2011) Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses. Mass Spectrometry Reviews doi:10.1002/mas.20342.
28. Vance JE, Vance DE, (2004) Phospholipid biosynthesis in mammalian cells. Biochemistry and Cell Biology 82: 113-128.
29. Smith CA, O'Maille G, Want EJ, Qin C, Trauger SA, et al. (2005) METLIN: a metabolite mass spectral database. Therapeutic Drug Monitoring 27: 747-751.
30. Kind T, Wohlgemuth G, Lee DY, Lu Y, Palazoglu M, et al. (2009) FiehnLib: Mass Spectral and Retention Index Libraries for Metabolomics Based on Quadrupole and Time-of-Flight Gas Chromatography/Mass Spectrometry. Analytical Chemistry 81: 10038-10048.
31. Barupal DK, Haldiya PK, Wohlgemuth G, Kind T, Kothari SL, et al. (2012) MetaMapp: Mapping and visualizing metabolomic data by integrating information from biochemical pathways and chemical and mass spectral similarity. BMC Bioinformatics 13: 99.
32. Hartman AL, Lough DM, Barupal DK, Fiehn O, Fishbein T, et al. (2009) Human gut microbiome adopts an alternative state following small bowel transplantation. Proceedings of the National Academy of Sciences of the United States of America 106: 17187-17192.
33. Pegg AE, Coward JK, (1985) Growth of mammalian cells in the absence of the accumulation of spermine. Biochemical and Biophysical Research Communications 133: 82-89.
34. Avila MA, Garcýa-Trevijano ER, Lub SC, Corrales FJ, Matoc JM, (2004) Methylthioadenosine. The International Journal of Biochemistry and Cell Biology 36: 2125-2130.
35. Moriwaki Y, Yamamoto T, Higashino K, (1999) Enzymes involved in purine metabolism- A review of histochemical localization and functional implications. Histology and Histopathology 14: 1321-1340.
36. Annesley TM, (2003) Ion Suppression in Mass Spectrometry. Clinical Chemistry 49: 1041-1044.
37. Folmes CDL, Nelson TJ, Martinez-Fernandez A, Lindor JZ, Dzeja PP, et al. (2011) Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metabolism 14: 264-271.
38. Prigione A, Fauler B, Lurz R, Lehrach H, Adjaye J, (2010) The Senescence-Related Mitochondrial/Oxidative Stress Pathway is Repressed in Human Induced Pluripotent Stem Cells. Stem Cells 28: 721-733.
39. Warburg O, (1956) On respiratory impairment in cancer cells. Science (New York, NY) 124: 269.
40. Metallo CM, Gameiro PA, Bell EL, Mattaini KR, Yang J, et al. (2011) Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481: 380-384.
41. Tomoda K, Takahashi K, Leung K, Okada A, Narita M, et al. (2012) Derivation Conditions Impact X-Inactivation Status in Female Human Induced Pluripotent Stem Cells. Cell Stem Cell 11: 91-99.
42. Anguera MC, Sadreyev R, Zhang Z, Szanto A, Payer B, et al. (2012) Molecular Signatures of Human Induced Pluripotent Stem Cells Highlight Sex Differences and Cancer Genes. Cell Stem Cell 11: 75-90.
43. Munoz J, Low TY, Kok YJ, Chin A, Frese CK, et al. (2011) The quantitative proteomes of human-induced pluripotent stem cells and embryonic stem cells. Molecular systems biology 7.
44. Shi Y, Desponts C, Do JT, Hahm HS, Schöler HR, et al. (2008) Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3: 568-574.
45. Pegg AE, McCann PP, (1982) Polyamine metabolism and function. The American Journal of Physiology 243: C212-221.
46. Fiehn O, Garvey WT, Newman JW, Lok KH, Hoppel CL, et al. (2010) Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. PLoS One 5: e15234.
47. Fiehn O, Wohlgemuth G, Scholz M, (2005) Setup and Annotation of Metabolomic Experiments by Integrating Biological and Mass Spectrometric Metadata. Lecture Notes in Computer Science 3615: 224-239.
48. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, et al. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research 13: 2498-2504.